Summer Seminar Session 3

We will be discussing eligibility and recruitment in past and ongoing clinical trials for AD with a focus on implications for clinical care and generating evidence for interventions.   

For reference on Active Trials: https://www.nia.nih.gov/research/ongoing-AD-trials

• Anderson TS, Ayanian JZ, Souza J, Landon BE. Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment. 
• Ashford MT, Tank R, Kabeto MU, et al. Exclusions affect representativeness of Alzheimer’s disease trial participants. 

For more information regarding this seminar series, please contact jul291@pitt.edu.